Bone involvement as a presentation of breast cancer metastasis, clinical case presentation
DOI:
https://doi.org/10.56294/sctconf2024633Keywords:
Bone Metastases, Breast Cancer, Ovarian Cancer, Bone CancerAbstract
Occult breast cancer is that involvement that manifests as a metastatic axillary lymph node, without clinical or radiological manifestation of primary breast tumor. It is an infrequent affectation and was previously referred only to those lesions that were not palpable. On the other hand, metastasis is the process by which a primary cancerous focus spreads to another organ. This spread takes place via the blood or lymphatic route. The organs that cause bone metastasis are the breast, lung and prostate, in male patients, at present there is a high percentage of clinical cases published concerning bone involvement of breast origin and it is because of this and the form of presentation, coupled with the metastatic aggressiveness that we observed is that in this paper we detail the clinical case of a female patient with metastasis of occult breast cancer, where several organs were affected
References
1. Dornelles, P. (2015). Conocimiento del cáncer de mama y cáncer de mama hereditario en el personal de enfermería personal de enfermería de un hospital público. Revista Latino-Americana de Enfermagem, 90–97.
2. Hasbún Acuña, P., Vial Letelier, V., Correa Gutiérrez, H., Lechuga Ramírez, M., Pérez Rivera, M., Muñoz Leiva, D., & Vial Letelier, I. (2017). Metástasis cutáneas de cáncer de mama: revisión de la literatura. Revista Chilena de Cirugía, 69(1), 84–88.
3. Fj A-F, Ea L-G, De Tejada Valdivia S, Correspondencia T. ARTÍCULO ESPECIAL [Internet]. Samfyc.es. [citado el 25 de septiembre de 2023]. Disponible en: https://www.samfyc.es/wp-content/uploads/2018/10/v18n1_artEspecial_lesiones.pdf
4. Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005 Aug;5(8):591-602. doi: 10.1038/nrc1670. PMID: 16056258.
5. Mohla S, Weilbacher KN, Cher ML, Oyajobi BO, Poznak CV, Clohisy DR. Third north american symposium on skeletal complications of malignancy: summary of the scientific sessions. Cancer 2003;97:719-25.
6. Kahn D, Weiner GJ, Ben-Haim S, Ponto ll, Madsen MT, Bushnell DL, et al. Positron emission tomographic measurement of bone marrow blood flow to the pelvis and lumbar vertebrae in young normal adults. Blood 1994;83:958-63.
7. Mundy GR, Chen D, Zhao M, Dallas S, Xu C, Harris S. Growth regulatory factors and bone. Rev Endocr Metab Disord 2001;2:105-15.
8. Sosnoski DM, Krishnan V, Kraemer WJ, Dunn-Lewis C, Mastro AM. Changes in cytokines of the bone microenvironment during breast cancer metastasis. Int J Breast Cancer 2012;2012:160265.
9. Uehara M, Kinoshita T, Hojo T, et al. Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer. Int J Clin Oncol. Oct 2008; 13(5): 447-51
10. Orel S, Weinstein S, Schnall M, Reynolds C, Schuchter L, Fraker D et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999; 212: 543-9.
11. Sadako AT, Takashi F, Kunihisa M, Nashiko U, Takeshi N, Hitoshi T. Contrast-enhanced computed tomography detection of occult breast cancers presenting as axillary masses. Breast Cancer Research and Treatment 1999; 55: 97-101.
12. Sakorafas GH, Tsiotou AG. Occult breast cancer: a challenge from a surgical perspective. Surg Oncol 1999; 8: 27-33
13. Lloyd MS, Nash AG. Occult breast cancer. Ann R Coll Surg Engl 2001; 83: 420-4
Published
Issue
Section
License
Copyright (c) 2024 Ronald Vladimir Revelo Mera, Bolívar Alfredo Potes Berzosa, Alejandro Julián Terreros Bueno, Geovanna Paola Jaramillo Calderón, Rómulo Daniel Vargas Sánchez (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.